Therefore, our intent has been to specifically evaluate whether or not diet-induced obesity was able to cooperate with oncogenic Kras (G12D mutation) to accelerate tumorigenesis and to promote tumor progression in our model and, consequently, if the model itself could be used as a biological source for the identification of biomarkers and determinants of disease progression. The gene discussed is KRAS; the disease is neoplasm.